Bayer cooperates with PAPACKS to jointly develop alternative packaging for consumer health products

10 June 2024

Bayer has launched a strategic collaboration with PAPACKS to develop fiber-based packaging as an alternative to traditional plastic packaging for some of the company's consumer health products, which include brands such as Aspirin, Bepanthen and Claritin. This is a step forward in Bayer's commitment to ensure that 100% of the packaging of its self-care products contributes to the circular economy and is recyclable or reusable by 2030.

The collaboration aims to develop biodegradable pulp-based packaging made from responsible new fibres using PAPACKS' molded pulp technology, which uses materials from renewable sources and a plant-based coating.

“Reducing plastic consumption is one of our industry’s biggest challenges, so we are proud to partner with PAPACKS to accelerate progress toward using environmentally friendly, renewable sources for our packaging,” said Jesse DelGigante, Director of Global Packaging Innovation for Bayer’s Consumer Health Division. “This collaboration is a strong step forward on our journey toward sustainable packaging.”

“We look forward to the challenge of combining our unique plant-based coated pulp technology with the rigorous standards required by over-the-counter drug regulators,” said Tahsin Dag, founder and CEO of Papacks.

“We expect this collaboration to help redefine packaging standards for the industry.” As part of Bayer’s commitment to promoting sustainable packaging solutions, this collaboration with PAPACKS follows the recent announcement that the company has joined the Blister Pack Collective to reduce single-use plastics in healthcare packaging.